Ryaltris Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Per spray Olopatadine HCl 600 mcg, mometasone furoate 25 mcg

Indications/Uses

Symptomatic treatment of seasonal or perennial allergic rhinitis & associated ocular symptoms in adults & childn ≥6 yr.

Click to view Ryaltris detailed prescribing information

Dosage/Direction for Use

Adult & adolescent ≥12 yr 2 sprays in each nostril bd. Childn 6-11 yr 1 spray in each nostril bd.

Click to view Ryaltris detailed prescribing information

Overdosage

View Ryaltris overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity. Untreated fungal, bacterial or TB resp tract infections.

Click to view Ryaltris detailed prescribing information

Special Precautions

Discontinue use if localized nose or pharynx fungal infection develops; persistent nasopharyngeal irritation occurs. Not to be used in presence of untreated localized infection involving nasal mucosa; recent nasal surgery/trauma. Adrenal insufficiency, reversible hypothalamic-pituitary-adrenal axis suppression. Epistaxis; nasal ulceration & septal perforation; increased IOP; visual disturbances eg, cataract, glaucoma or central serous chorioretinopathy. Immunosuppressed patients; transferring from systemic corticosteroid treatment. Long-term use. Avoid contact w/ eyes or mouth. May affect ability to drive & operate machinery. Pregnancy & lactation. Childn <6 yr; monitor growth velocity reduction in childn.

Click to view Ryaltris detailed prescribing information

Use In Pregnancy & Lactation

Click to view Ryaltris detailed prescribing information

Adverse Reactions

Dysgeusia; epistaxis, nasal discomfort.

Click to view Ryaltris detailed prescribing information

Drug Interactions

Increased risk of systemic side effects w/ CYP3A inhibitors eg, ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nelfinavir, saquinavir, ritonavir, cobicistat-containing products. Reduced alertness & additional CNS impairment w/ alcohol or other CNS depressants.

Click to view Ryaltris detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Ryaltris detailed prescribing information

Storage

View Ryaltris storage conditions for details to ensure optimal shelf-life.

Description

View Ryaltris description for details of the chemical structure and excipients (inactive components).

Action

View Ryaltris mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Nasal Decongestants & Other Nasal Preparations

ATC Classification

R01 - NASAL PREPARATIONS ; Used in nasal preparations.

Regulatory Classification

Patient Counseling Information

View Ryaltris patient counselling information

Presentation/Packing

Form

Ryaltris nasal spray

Packing/Price

120 spray x 1's;240 spray x 1's;56 spray x 1's

Ryaltris

Manufacturer:

Glenmark Pharma

Distributor:

Uni Drug House